BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33571361)

  • 1. Performance Characteristics of Mutational Signature Analysis in Targeted Panel Sequencing.
    Lawrence L; Kunder CA; Fung E; Stehr H; Zehnder J
    Arch Pathol Lab Med; 2021 Nov; 145(11):1424-1431. PubMed ID: 33571361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational signature analysis in non-small cell lung cancer patients with a high tumor mutational burden.
    van den Heuvel GRM; Kroeze LI; Ligtenberg MJL; Grünberg K; Jansen EAM; von Rhein D; de Voer RM; van den Heuvel MM
    Respir Res; 2021 Nov; 22(1):302. PubMed ID: 34819052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tobacco Smoking-Related Mutational Signatures in Classifying Smoking-Associated and Nonsmoking-Associated NSCLC.
    Ernst SM; Mankor JM; van Riet J; von der Thüsen JH; Dubbink HJ; Aerts JGJV; de Langen AJ; Smit EF; Dingemans AC; Monkhorst K
    J Thorac Oncol; 2023 Apr; 18(4):487-498. PubMed ID: 36528243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dramatic response of metastatic cutaneous angiosarcoma to an immune checkpoint inhibitor in a patient with xeroderma pigmentosum: whole-genome sequencing aids treatment decision in end-stage disease.
    Momen S; Fassihi H; Davies HR; Nikolaou C; Degasperi A; Stefanato CM; Dias JML; Dasgupta D; Craythorne E; Sarkany R; Papa S; Nik-Zainal S
    Cold Spring Harb Mol Case Stud; 2019 Oct; 5(5):. PubMed ID: 31645345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel POLE pathogenic germline variant in a family with multiple primary tumors results in distinct mutational signatures.
    Castellsagué E; Li R; Aligue R; González S; Sanz J; Martin E; Velasco À; Capellá G; Stewart CJR; Vidal A; Majewski J; Rivera B; Polak P; Matias-Guiu X; Brunet J; Foulkes WD
    Hum Mutat; 2019 Jan; 40(1):36-41. PubMed ID: 30362666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological characteristics of POLE mutation in patients with non-small-cell lung cancer.
    Song Z; Cheng G; Xu C; Wang W; Shao Y; Zhang Y
    Lung Cancer; 2018 Apr; 118():57-61. PubMed ID: 29572003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular classification of pulmonary sarcomatoid carcinomas suggests new therapeutic opportunities.
    Pécuchet N; Vieira T; Rabbe N; Antoine M; Blons H; Cadranel J; Laurent-Puig P; Wislez M
    Ann Oncol; 2017 Jul; 28(7):1597-1604. PubMed ID: 28419182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid clinical mutational testing of
    Van Haele M; Vander Borght S; Ceulemans A; Wieërs M; Metsu S; Sagaert X; Weynand B
    J Clin Pathol; 2020 Jan; 73(1):35-41. PubMed ID: 31296605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53, Mismatch Repair Protein, and POLE Abnormalities in Ovarian Clear Cell Carcinoma: An Outcome-based Clinicopathologic Analysis.
    Parra-Herran C; Bassiouny D; Lerner-Ellis J; Olkhov-Mitsel E; Ismiil N; Hogen L; Vicus D; Nofech-Mozes S
    Am J Surg Pathol; 2019 Dec; 43(12):1591-1599. PubMed ID: 31335355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation of immune status with ultraviolet radiation-associated mutations in cutaneous squamous cell carcinoma: A case-control study.
    Lobl MB; Clarey D; Higgins S; Thieman T; Wysong A
    J Am Acad Dermatol; 2020 May; 82(5):1230-1232. PubMed ID: 31704220
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of SDHD promoter mutations in various types of melanoma.
    Scholz SL; Horn S; Murali R; Möller I; Sucker A; Sondermann W; Stiller M; Schilling B; Livingstone E; Zimmer L; Reis H; Metz CH; Zeschnigk M; Paschen A; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
    Oncotarget; 2015 Sep; 6(28):25868-82. PubMed ID: 26327518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline
    Lindsay H; Scollon S; Reuther J; Voicu H; Rednam SP; Lin FY; Fisher KE; Chintagumpala M; Adesina AM; Parsons DW; Plon SE; Roy A
    Cold Spring Harb Mol Case Stud; 2019 Oct; 5(5):. PubMed ID: 31624068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular profiling of key driver genes improves staging accuracy in multifocal non-small cell lung cancer.
    Zheng R; Shen Q; Mardekian S; Solomides C; Wang ZX; Evans NR
    J Thorac Cardiovasc Surg; 2020 Aug; 160(2):e71-e79. PubMed ID: 32007245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. POLE somatic mutations in advanced colorectal cancer.
    Guerra J; Pinto C; Pinto D; Pinheiro M; Silva R; Peixoto A; Rocha P; Veiga I; Santos C; Santos R; Cabreira V; Lopes P; Henrique R; Teixeira MR
    Cancer Med; 2017 Dec; 6(12):2966-2971. PubMed ID: 29072370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants.
    Hocker T; Tsao H
    Hum Mutat; 2007 Jun; 28(6):578-88. PubMed ID: 17295241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The specificity of p53 mutation spectra in sunlight induced human cancers.
    Daya-Grosjean L; Dumaz N; Sarasin A
    J Photochem Photobiol B; 1995 May; 28(2):115-24. PubMed ID: 7636632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The somatic POLE P286R mutation defines a unique subclass of colorectal cancer featuring hypermutation, representing a potential genomic biomarker for immunotherapy.
    Ahn SM; Ansari AA; Kim J; Kim D; Chun SM; Kim J; Kim TW; Park I; Yu CS; Jang SJ
    Oncotarget; 2016 Oct; 7(42):68638-68649. PubMed ID: 27612425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of a large cohort of non-small cell lung cancers submitted for somatic variant analysis demonstrates that targeted next-generation sequencing is fit for purpose as a molecular diagnostic assay in routine practice.
    Moore DA; Balbi K; Ingham A; Arkenau HT; Bennett P
    J Clin Pathol; 2018 Nov; 71(11):1001-1006. PubMed ID: 30054375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long tail of molecular alterations in non-small cell lung cancer: a single-institution experience of next-generation sequencing in clinical molecular diagnostics.
    Fumagalli C; Vacirca D; Rappa A; Passaro A; Guarize J; Rafaniello Raviele P; de Marinis F; Spaggiari L; Casadio C; Viale G; Barberis M; Guerini-Rocco E
    J Clin Pathol; 2018 Sep; 71(9):767-773. PubMed ID: 29535211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to PD-1 Blockade in Microsatellite Stable Metastatic Colorectal Cancer Harboring a
    Gong J; Wang C; Lee PP; Chu P; Fakih M
    J Natl Compr Canc Netw; 2017 Feb; 15(2):142-147. PubMed ID: 28188185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.